Is there a role for endothelin antagonists in diabetic renal disease?

Diabetes Obes Metab. 2000 Jan;2(1):15-24. doi: 10.1046/j.1463-1326.2000.00045.x.

Authors

K Jandeleit-Dahm¹, T J Allen, S Youssef, R E Gilbert, M E Cooper

Affiliation

¹ Department of Medicine, University of Melbourne, Heidelberg West, Australia.

PMID: 11220349
DOI: 10.1046/j.1463-1326.2000.00045.x

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Aspartic Acid Endopeptidases / metabolism
Diabetes Complications*
Diabetic Nephropathies / drug therapy
Diabetic Nephropathies / physiopathology*
Disease Models, Animal
Endothelin Receptor Antagonists*
Endothelin-Converting Enzymes
Endothelins / physiology*
Humans
Hypertension, Renal / etiology
Hypertension, Renal / physiopathology
Metalloendopeptidases
Rats

Substances

Endothelin Receptor Antagonists
Endothelins
Aspartic Acid Endopeptidases
Metalloendopeptidases
Endothelin-Converting Enzymes